All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Does TRT really kill fertility, and can you protect yourself?

MTM

TikTok creator

10.1K viewsWatch on TikTok→

Quick answer

Exogenous testosterone suppresses the HPG axis, reducing intratesticular testosterone and impairing spermatogenesis in a significant proportion of men within 3 to 6 months of initiation. HCG (human chorionic gonadotropin) acts as an LH analog at Leydig cell receptors and has evidence supporting its use to preserve intratesticular testosterone during exogenous androgen administration (Coviello et al., 2005, JCEM). Clomiphene citrate operates upstream of this mechanism and retains clinical utility in hypogonadal men who have not initiated exogenous testosterone or during post-TRT recovery, contrary to the creator's broad dismissal.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @morethanmuscle.nicholas actually say?

The creator made three specific claims: exogenous testosterone reduces fertility by "about 60 to 90% in the first four months," clomiphene is useless on TRT because LH and FSH are "dead circuits," and HCG is the only viable fertility-preservation strategy because it mimics LH directly at the testicular receptor. He then disclosed his personal protocol of 500 IUs two to three times weekly.

The core argument follows a real physiological chain: exogenous testosterone suppresses the hypothalamic-pituitary-gonadal (HPG) axis, shutting down gonadotropin release, which starves the testes of the signal they need for spermatogenesis. That logic is not invented. The question is how well his specific claims hold up against published data, and whether the clomiphene dismissal is as clean as he made it sound.

Does the science back this up?

Largely yes on suppression, mostly yes on HCG, and significantly oversimplified on clomiphene. The fertility impact of exogenous testosterone is well-documented and serious. The HCG argument has real mechanistic support. The clomiphene claim is where the video earns its asterisk.

On suppression: a landmark study by Contraceptive Clinical Trials Group (WHO, 1990, Lancet) showed that testosterone enanthate at 200 mg weekly achieved azoospermia or severe oligospermia in a substantial majority of men within 3 to 6 months. Coviello et al. (2005, Journal of Clinical Endocrinology and Metabolism) confirmed that intratesticular testosterone, not serum testosterone, drives spermatogenesis, and exogenous testosterone collapses intratesticular levels while raising serum levels. So the "60 to 90%" fertility reduction framing, while imprecise, reflects a real and fast process.

On HCG: it binds directly to LH receptors on Leydig cells, stimulating intratesticular testosterone production independently of the suppressed HPG axis. Coviello et al. (2005) specifically showed HCG co-administration preserved intratesticular testosterone even during exogenous testosterone use. That is the core of his argument, and it is sound.

What did they get wrong (or right)?

The clomiphene dismissal is too absolute, and that matters clinically. He said clomiphene "will only work if your LH and your FSH are still sending a signal," which is technically accurate as a mechanism. But he framed it as if clomiphene has zero role in this space, which misses a real use case: recovery after TRT cessation, or in men who never started TRT and want to preserve fertility while boosting testosterone.

Ramasamy et al. (2014, Journal of Urology) demonstrated that clomiphene citrate effectively raised testosterone and maintained spermatogenesis in hypogonadal men who had not yet started exogenous testosterone. The drug works upstream, stimulating the pituitary, which only matters if the pituitary is still receiving hypothalamic input. He is right that once you are on exogenous testosterone, that pathway is suppressed. But the implication that clomiphene is simply useless in the fertility conversation is a meaningful overstatement.

The "60 to 90%" figure is directionally accurate but presented without context. Suppression rates and severity vary by dose, ester, individual baseline, and duration. Framing it as a single clean statistic glosses over real variability.

Credit where it is due: his mechanistic explanation of HCG acting as the signal rather than triggering a signal is a genuinely clear and accurate description of how the drug works at the receptor level.

What should you actually know?

Testosterone replacement therapy meaningfully suppresses spermatogenesis, often within months of starting. This is not hypothetical risk. It is a predictable pharmacological outcome that anyone considering TRT who may want biological children should discuss with a reproductive endocrinologist or urologist before starting, not after.

HCG co-administration has legitimate evidence behind it for preserving intratesticular testosterone during TRT. It is not a fringe idea. However, long-term fertility outcomes with HCG co-administration are not as robustly studied as the creator's confidence might imply. Recovery of spermatogenesis after TRT cessation is also possible in many men, though timelines vary and are not guaranteed.

Clomiphene is not dead in this conversation. It plays a real role in specific scenarios, particularly for men who have not yet started TRT or as part of post-TRT recovery protocols. Dismissing it entirely gives an incomplete picture.

Anyone on TRT who is concerned about fertility should get a semen analysis, discuss gonadotropin-based strategies with a physician, and not base clinical decisions on a 60-second TikTok, including this one. The creator disclosed his own protocol, which is not a prescription or recommendation you should replicate without individualized medical evaluation.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Does TRT really kill fertility, and can you protect yourself?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Does TRT really kill fertility, and can you protect yourself? is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

Compare providers, services and access requirements in the directory before contacting a suitable care team.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Claim verdict

The useful answer behind this video

Claim being checked

Exogenous testosterone suppresses the HPG axis, reducing intratesticular testosterone and impairing spermatogenesis in a significant proportion of men within 3 to 6 months of initiation.

FormBlends verdict

Exogenous testosterone suppresses the HPG axis, reducing intratesticular testosterone and impairing spermatogenesis in a significant proportion of men within 3 to 6 months of initiation. HCG (human chorionic gonadotropin) acts as an LH analog at Leydig cell receptors and has evidence supporting its use to preserve intratesticular testosterone during exogenous androgen administration (Coviello et al., 2005, JCEM). Clomiphene citrate operates upstream of this mechanism and retains clinical utility in hypogonadal men who have not initiated exogenous testosterone or during post-TRT recovery, contrary to the creator's broad dismissal.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Exogenous testosterone suppresses the HPG axis, reducing intratesticular testosterone and impairing spermatogenesis in a significant proportion of men within 3 to 6 months of initiation. HCG (human chorionic gonadotropin) acts as an LH analog at Leydig cell receptors and has evidence supporting its use to preserve intratesticular testosterone during exogenous androgen administration (Coviello et al., 2005, JCEM). Clomiphene citrate operates upstream of this mechanism and retains clinical utility in hypogonadal men who have not initiated exogenous testosterone or during post-TRT recovery, contrary to the creator's broad dismissal.
  • Exogenous testosterone suppresses spermatogenesis in a majority of men: WHO Contraceptive Clinical Trials (Lancet, 1990) showed most men reached azoospermia or severe oligospermia within 3 to 6 months of weekly testosterone enanthate injections.
  • Intratesticular testosterone, not serum testosterone, drives sperm production. Coviello et al. (2005, JCEM) showed exogenous testosterone collapses intratesticular levels even when serum levels are elevated.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Exogenous testosterone suppresses spermatogenesis in a majority of men: WHO Contraceptive Clinical Trials (Lancet, 1990) showed most men reached azoospermia or severe oligospermia within 3 to 6 months of weekly testosterone enanthate injections.
  • Intratesticular testosterone, not serum testosterone, drives sperm production. Coviello et al. (2005, JCEM) showed exogenous testosterone collapses intratesticular levels even when serum levels are elevated.
  • HCG preserves intratesticular testosterone during TRT by acting directly on Leydig cell LH receptors, bypassing the suppressed HPG axis. This mechanism is well-established in the literature.
  • Clomiphene is not useless in fertility contexts. Ramasamy et al. (2014, Journal of Urology) showed it effectively maintained spermatogenesis in men with hypogonadism who had not started exogenous testosterone.
  • Spermatogenesis can recover after TRT cessation in many men, but timelines range from months to over a year and recovery is not guaranteed. Starting TRT without a fertility plan is a one-way door for an uncertain period.
  • Anyone considering TRT who may want biological children should consult a reproductive urologist or endocrinologist before starting therapy, not after suppression has already occurred.
  • The creator's personal HCG protocol is not a prescription. Appropriate dosing and monitoring require individualized clinical evaluation.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

MTM · TikTok creator

10.1K views on this video

TRT kills fertility fast. Here’s how to protect yourself. #menshealth #morethanmuscle #fitnesstruth #healthoptimization

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by MTM, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.